Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Cerilliant
US Department of Justice
Merck
Cantor Fitzgerald
Federal Trade Commission
QuintilesIMS
Accenture
UBS

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 089180

« Back to Dashboard

NDA 089180 describes FOLEX PFS, which is a drug marketed by Pharmacia And Upjohn and is included in two NDAs. Additional details are available on the FOLEX PFS profile page.

The generic ingredient in FOLEX PFS is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
Summary for 089180
Tradename:FOLEX PFS
Applicant:Pharmacia And Upjohn
Ingredient:methotrexate sodium
Patents:0
Therapeutic Class:Immunological Agents
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 25MG BASE/ML
Approval Date:Jan 3, 1986TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Fuji
Fish and Richardson
Moodys
US Army
Johnson and Johnson
Chinese Patent Office
Boehringer Ingelheim
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.